FDA Inspection 1270954 — Eurofins Biopharma Product Testing Ireland Limited
The FDA completed an inspection of Eurofins Biopharma Product Testing Ireland Limited on May 26, 2023 in Dungarvan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 26, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dungarvan (Ireland)
Additional Details
Mutual Recognition Agreement (MRA)